<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46741">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02497755</url>
  </required_header>
  <id_info>
    <org_study_id>47871-EG</org_study_id>
    <nct_id>NCT02497755</nct_id>
  </id_info>
  <brief_title>Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety</brief_title>
  <official_title>Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot feasibility study of a mobile health tool (smartphone app) for primary care
      patients receiving treatment for depression or anxiety delivered in an integrated primary
      care-based behavioral health program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research is a feasibility pilot study of a smartphone app using mixed methods. The
      research seeks to answer the question: &quot;Is a mobile health tool for patient self-management
      feasible, useful, appropriate, and acceptable for patients and care managers for patients
      with depression or anxiety treated in an integrated primary-care based behavioral health
      program?&quot;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Acceptability as determined by qualitative interview.</measure>
    <time_frame>Four weeks after intervention started</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Care Manager Acceptability as determined by qualitative interview.</measure>
    <time_frame>8-16 weeks after final patient participant is enrolled</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient report of usefulness as determined by qualitative interview.</measure>
    <time_frame>Four weeks after intervention started</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Care manager report of usefulness as determined by qualitative interview.</measure>
    <time_frame>8-16 weeks after final patient participant is enrolled</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technology acceptability as measured by the Obtrusiveness Scale for Pervasive Technology (modified)</measure>
    <time_frame>During weeks 3 and 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction as measured by the Ginger.io product feedback survey.</measure>
    <time_frame>Days 30, 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient use as measured by proportion of surveys completed.</measure>
    <time_frame>Eight weeks after intervention started</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Care team communication as measured by the Consumer Assessment of Healthcare Providers and Systems (CAHPS) - Communication scale</measure>
    <time_frame>Weeks 4 and 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Care process measures as measured by the number and type of contacts with care manager.</measure>
    <time_frame>Eight weeks after intervention started</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Mobile app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will install an app on their smartphone to add to their treatment for depression and/or anxiety.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>App for smartphone</intervention_name>
    <description>A smartphone app will send psychoeducation and reminders to patients to complete self-report data, will collect passive data, and will provide aggregated information to a provider dashboard.</description>
    <arm_group_label>Mobile app</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>smartphone</intervention_name>
    <arm_group_label>Mobile app</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be part of the Behavioral Health Integration Program for anxiety and/or depression;
             Must have an iPhone or Android smartphone with a mobile voice calling plan with a US
             carrier; Fluent in English

        Exclusion Criteria:

          -  Individual unable or unwilling to accept the terms of the Ginger.io terms of Use;
             Actively suicidal as determined by a healthcare professional; score of 3 on the
             Patient Health Questionnaire-9 item 9 (which assesses thoughts of self-harm); or
             documented history of 2 or more prior suicide attempts; Working diagnosis of
             psychotic disorder, bipolar disorder, dementia, active substance dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy M Bauer, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Washington Neighborhood Clinic, Ravenna</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 30, 2015</lastchanged_date>
  <firstreceived_date>February 14, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Amy Bauer</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
